CLCN2 chloride channel mutations in familial hyperaldosteronism type II
Autor/innen
- U.I. Scholl
- G. Stölting
- J. Schewe
- A. Thiel
- H. Tan
- C. Nelson-Williams
- A.A. Vichot
- S.C. Jin
- E. Loring
- V. Untiet
- T. Yoo
- J. Choi
- S. Xu
- A. Wu
- M. Kirchner
- P. Mertins
- L.C. Rump
- A.M. Onder
- C. Gamble
- D. McKenney
- R.W. Lash
- D.P. Jones
- G. Chune
- P. Gagliardi
- M. Choi
- R. Gordon
- M. Stowasser
- C. Fahlke
- R.P. Lifton
Journal
- Nature Genetics
Quellenangabe
- Nat Genet 50 (3): 349-354
Zusammenfassung
Primary aldosteronism, a common cause of severe hypertension 1 , features constitutive production of the adrenal steroid aldosterone. We analyzed a multiplex family with familial hyperaldosteronism type II (FH-II) 2 and 80 additional probands with unsolved early-onset primary aldosteronism. Eight probands had novel heterozygous variants in CLCN2, including two de novo mutations and four independent occurrences of a mutation encoding an identical p.Arg172Gln substitution; all relatives with early-onset primary aldosteronism carried the CLCN2 variant found in the proband. CLCN2 encodes a voltage-gated chloride channel expressed in adrenal glomerulosa that opens at hyperpolarized membrane potentials. Channel opening depolarizes glomerulosa cells and induces expression of aldosterone synthase, the rate-limiting enzyme for aldosterone biosynthesis. Mutant channels show gain of function, with higher open probabilities at the glomerulosa resting potential. These findings for the first time demonstrate a role of anion channels in glomerulosa membrane potential determination, aldosterone production and hypertension. They establish the cause of a substantial fraction of early-onset primary aldosteronism.